Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer.

Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer. Drugs Today (Barc). 2004 Sep; 40(9):751-64.

View in: PubMed